|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500101017 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-18 08:49:38 |
|
注册时间: Date of Registration: |
2025-04-18 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
肺癌患者胸腔镜术后营养不良风险预测模型的构建及验证 |
|
Public title: |
Construction and Validation of a Prediction Model for the Risk of Malnutrition in Lung - cancer Patients after Thoracoscopic Surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
肺癌患者胸腔镜术后营养不良风险预测模型的构建及验证 |
|
Scientific title: |
Construction and Validation of a Prediction Model for the Risk of Malnutrition in Lung - cancer Patients after Thoracoscopic Surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈天凤 |
研究负责人: |
盘瑞兰 |
|
Applicant: |
Chen Tianfeng |
Study leader: |
Pan Ruilan |
|
申请注册联系人电话: Applicant telephone: |
+86 138 2485 2451 |
研究负责人电话: Study leader's telephone: |
+86 133 1661 9688 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
925923620@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
dg149@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省东莞市万江区新谷涌万道路南 3 号 |
研究负责人通讯地址: |
广东省东莞市万江区新谷涌万道路南 3 号 |
|
Applicant address: |
No. 3, South Wandao Road, Xingu Valley Yong, Wanjiang District, Dongguan City, Guangdong Province |
Study leader's address: |
No. 3, South Wandao Road, Xingu Valley Yong, Wanjiang District, Dongguan City, Guangdong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
广东医科大学 |
||
|
Applicant's institution: |
I am a student of this school. |
||
|
研究负责人所在单位: |
广东省东莞市人民医院 |
||
|
Affiliation of the Leader: |
I'm the head nurse of this hospital. |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KYKT2025-011 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
东莞市人民医院道德伦理委员会 |
||
|
Name of the ethic committee: |
The Moral and Ethical Committee of Dongguan People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-02-19 00:00:00 |
||
|
伦理委员会联系人: |
袁领勤 |
||
|
Contact Name of the ethic committee: |
Lingqin Yuan |
||
|
伦理委员会联系地址: |
广东省东莞市人民医院红楼院区伦理委员会 |
||
|
Contact Address of the ethic committee: |
Ethics Committee of Honglou Campus, Dongguan People's Hospital, Guangdong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 769 2863 6365 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
dgrmyyirb@163.com |
|
研究实施负责(组长)单位: |
广东省东莞市人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Dongguan People's Hospital, Guangdong Province |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省东莞市万江区新谷涌万道路南 3 号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 3, South Wandao Road, Xingu Valley Yong, Wanjiang District, Dongguan City, Guangdong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无经费来源 |
||||||||||||||||||||||
|
Source(s) of funding: |
No financial support. |
||||||||||||||||||||||
|
Target disease: |
lung cancer |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
构建一个更全面、更具临床应用价值的肺癌患者营养不良风险预测模型,为肺癌患者VATS手术后的营养管理提供更精确、更具针对性的预测工具。 |
||||||||||||||||||||||
|
Objectives of Study: |
The aim is to construct a comprehensive and highly clinically applicable risk prediction model for malnutrition in lung cancer patients. This model will provide a precise and highly targeted prediction tool for the nutritional management of lung cancer patients after video - assisted thoracoscopic surgery (VATS), enabling clinical doctors to more effectively formulate personalized nutritional intervention plans and improve the quality of postoperative rehabilitation and the living standards of patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.接受了胸腔镜肺切除手术(VATS); 2.术后病理诊断为肺癌(根据AJCC第8版TNM分期); 3.有完整的临床资料和实验室检查数据。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Have undergone video-assisted thoracoscopic surgery (VATS) for pulmonary resection; 2. Have been pathologically diagnosed with lung cancer postoperatively (in accordance with the 8th edition of the AJCC TNM staging system ); 3. Have complete clinical data and laboratory examination results. |
||||||||||||||||||||||
|
排除标准: |
1.合并其他原发性恶性肿瘤; 2.术前已发生营养不良; 3.术前已行放疗、化疗、新辅助治疗或靶向治疗; 4.术中发生严重并发症导致手术方案显著改变(如中转开胸); 5.合并严重的心脑肾等其他脏器器质性病变或功能不全。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Combined with other primary malignant tumors; 2. Suffered from malnutrition before the operation; 3. Had received radiotherapy, chemotherapy, neoadjuvant therapy or targeted therapy before the operation; 4. Experienced serious complications during the operation, leading to significant changes in the surgical plan (such as conversion to thoracotomy); 5. Combined with severe organic lesions or functional insufficiency of other organs such as the heart, brain and kidneys. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-02-19 00:00:00至 To 2026-02-19 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-05-11 00:00:00 至 To 2026-02-19 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
none |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
none |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
do not share |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |